Welcome to Novo Nordisk Science Hub

Are you a healthcare professional?

OW 2026 15 November 2026

Effect of Cagrilintide 2.4 mg on food cravings and eating behavior: REDEFINE 1 post hoc analysis

Sorry! It looks like the page you are trying to access contains materials that are still under embargo. Please come back and check again later.
Keywords
Obesity
Congress oral presentation
Amylin
Cagrilintide
PHASE 3 (RCT)